Thank you for helping us ensure vulnerable heart failure patients have access to safe, effective infusion care in the comfort of their homes.
On February 9, 2018, Congress passed legislation that included a temporary payment fix to the reimbursement gap created by the 21st Century Cures Act. Under the new law, reimbursement for clinical services delivered by home infusion companies to patients under Medicare Part B will now be paid starting on January 1, 2019 – two years earlier than those services were set to be paid under the Cures Act.
This is a major victory for home infusion patients and is the direct result of the advocacy efforts of patients, caregivers and providers. Through our combined efforts, more than 1,000 letters were sent imploring lawmakers to fix this unintended consequence of the Cures Act on behalf of vulnerable heart failure patients.
Who We Are
Patients, families, caregivers, providers and other advocacy partners advocating for a vulnerable patient population negatively impacted by the 21st Century Cures Act.
Many patients with complex heath conditions receive medication via a needle or catheter in the comfort of their own homes. Home infusion provides a safe and effective alternative to inpatient care for many diseases and therapies, maintains quality of life, and is a much less costly alternative to treatment in a hospital or skilled nursing facility.